Artikel
Akt-the mammalian target of rapamycin (mTOR) pathway inhibition increases cervical cancer cell chemosensitivity to active form of irinotecan (SN-38)
IJIHS - International Journal of Integrated Health Sciences Vol. 1 No. 1 July 2013 (Rak 6-K : Kedokteran & Kesehatan)
Tidak tersedia versi lain